{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T04:05:08Z","timestamp":1770782708857,"version":"3.50.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s13304-021-01109-0","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T17:02:52Z","timestamp":1623344572000},"page":"2095-2101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of two different surgical strategies for breast cancer patients treated with mastectomy plus sentinel lymph node biopsy"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4132-0505","authenticated-orcid":false,"given":"Xing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"1109_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/BCTT.S176070","volume":"11","author":"Z Momenimovahed","year":"2019","unstructured":"Momenimovahed Z, Salehiniya H (2019) Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer (Dove Medical Press) 11:151\u2013164. https:\/\/doi.org\/10.2147\/BCTT.S176070","journal-title":"Breast Cancer (Dove Medical Press)"},{"key":"1109_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1186\/s12885-019-6165-4","volume":"19","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Li Y, Mao F, Zhang J, Zhu Q, Shen S, Lin Y, Zhang X, Liu H, Xiao M, Jiang Y, Sun Q (2019) Preliminary study of contrast-enhanced ultrasound in combination with blue dye vs. indocyanine green fluorescence, in combination with blue dye for sentinel lymph node biopsy in breast cancer. BMC Cancer 19:939. https:\/\/doi.org\/10.1186\/s12885-019-6165-4","journal-title":"BMC Cancer"},{"key":"1109_CR3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","volume":"252","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252:426\u2013432. https:\/\/doi.org\/10.1097\/SLA.0b013e3181f08f32","journal-title":"Ann Surg"},{"key":"1109_CR4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH, Klinkenbijl JH, Orzalesi L, Bouma WH, van der Mijle HC, Nieuwenhuijzen GA, Veltkamp SC, Slaets L, Duez NJ, de Graaf PW, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ, Merkus JW, Belkacemi Y, Petignat P, Schinagl DA, Coens C, Messina CG, Bogaerts J, Rutgers EJ (2014) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15:1303\u20131310. https:\/\/doi.org\/10.1016\/S1470-2045(14)70460-7","journal-title":"Lancet Oncol"},{"key":"1109_CR5","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1200\/JCO.19.02576","volume":"38","author":"M Morrow","year":"2020","unstructured":"Morrow M, Khan AJ (2020) Locoregional management after neoadjuvant chemotherapy. J Clin Oncol 38:2281\u20132289. https:\/\/doi.org\/10.1200\/JCO.19.02576","journal-title":"J Clin Oncol"},{"key":"1109_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.20892\/j.issn.2095-3941.2018.0270","volume":"15","author":"L Yuan","year":"2018","unstructured":"Yuan L, Qi X, Zhang Y, Yang X, Zhang F, Fan L, Chen L, Zhang K, Zhong L, Li Y, Gan S, Fu W, Jiang J (2018) Comparison of sentinel lymph node detection performances using blue dye in conjunction with indocyanine green or radioisotope in breast cancer patients: a prospective single-center randomized study. Cancer Biol Med 15:452\u2013460. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2018.0270","journal-title":"Cancer Biol Med"},{"key":"1109_CR7","doi-asserted-by":"publisher","first-page":"6251468","DOI":"10.1155\/2018\/6251468","volume":"2018","author":"T Papathemelis","year":"2018","unstructured":"Papathemelis T, Jablonski E, Scharl A, Hauzenberger T, Gerken M, Klinkhammer-Schalke M, Hipp M, Scharl S (2018) Sentinel lymph node biopsy in breast cancer patients by means of indocyanine green using the Karl Storz VITOM\u00ae fluorescence camera. Biomed Res Int 2018:6251468. https:\/\/doi.org\/10.1155\/2018\/6251468","journal-title":"Biomed Res Int"},{"key":"1109_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10549-020-05842-9","volume":"184","author":"W Gao","year":"2020","unstructured":"Gao W, Zeng Y, Fei X, Chen X, Shen K (2020) Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other histological special types: a multi-institutional retrospective analysis. Breast Cancer Res Treat 184:193\u2013202. https:\/\/doi.org\/10.1007\/s10549-020-05842-9","journal-title":"Breast Cancer Res Treat"},{"key":"1109_CR9","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12282-018-0852-x","volume":"25","author":"Y Adachi","year":"2018","unstructured":"Adachi Y, Sawaki M, Hattori M, Yoshimura A, Gondo N, Kotani H, Iwase M, Kataoka A, Onishi S, Sugino K, Terada M, Horisawa N, Mori M, Oze I, Iwata H (2018) Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma. Breast cancer (Tokyo, Japan) 25:560\u2013565. https:\/\/doi.org\/10.1007\/s12282-018-0852-x","journal-title":"Breast cancer (Tokyo, Japan)"},{"issue":"7","key":"1109_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/annonc\/mdy537","volume":"30","author":"G Curigliano","year":"2019","unstructured":"Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn H-J, Th\u00fcrlimann B, Panel Members of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017 (2019) De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol 30(7):1181. https:\/\/doi.org\/10.1093\/annonc\/mdy537","journal-title":"Ann Oncol"},{"key":"1109_CR11","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1245\/s10434-020-08900-0","volume":"27","author":"MA Piltin","year":"2020","unstructured":"Piltin MA, Hoskin TL, Day CN, Davis J Jr, Boughey JC (2020) Oncologic outcomes of sentinel lymph node surgery after neoadjuvant chemotherapy for node-positive breast cancer. Ann Surg Oncol 27:4795\u20134801. https:\/\/doi.org\/10.1245\/s10434-020-08900-0","journal-title":"Ann Surg Oncol"},{"key":"1109_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1200\/JOP.2016.019992","volume":"13","author":"GH Lyman","year":"2017","unstructured":"Lyman GH, Somerfield MR, Giuliano AE (2017) Sentinel lymph node biopsy for patients with early-stage breast cancer: 2016 american society of clinical oncology clinical practice guideline update summary. J Oncol Pract 13:196\u2013198. https:\/\/doi.org\/10.1200\/JOP.2016.019992","journal-title":"J Oncol Pract"},{"key":"1109_CR13","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1200\/GO.20.00165","volume":"6","author":"SK Agrawal","year":"2020","unstructured":"Agrawal SK, Hashlamoun I, Karki B, Sharma A, Arun I, Ahmed R (2020) Diagnostic performance of indocyanine green plus methylene blue versus radioisotope plus methylene blue dye method for sentinel lymph node biopsy in node-negative early breast cancer. JCO Glob Oncol 6:1225\u20131231. https:\/\/doi.org\/10.1200\/GO.20.00165","journal-title":"JCO Glob Oncol"},{"key":"1109_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2325\/jbcs.12.211","volume":"12","author":"T Kitai","year":"2005","unstructured":"Kitai T, Inomoto T, Miwa M, Shikayama T (2005) Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 12:211\u2013215. https:\/\/doi.org\/10.2325\/jbcs.12.211","journal-title":"Breast Cancer"},{"key":"1109_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10549-013-2802-9","volume":"143","author":"FP Verbeek","year":"2014","unstructured":"Verbeek FP, Troyan SL, Mieog JS, Liefers GJ, Moffitt LA, Rosenberg M, Hirshfield-Bartek J, Gioux S, van de Velde CJ, Vahrmeijer AL, Frangioni JV (2014) Near-infrared fluorescence sentinel lymph node mapping in breast cancer: a multicenter experience. Breast Cancer Res Treat 143:333\u2013342. https:\/\/doi.org\/10.1007\/s10549-013-2802-9","journal-title":"Breast Cancer Res Treat"},{"key":"1109_CR16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12957-017-1264-7","volume":"15","author":"J Guo","year":"2017","unstructured":"Guo J, Yang H, Wang S, Cao Y, Liu M, Xie F, Liu P, Zhou B, Tong F, Cheng L, Liu H, Wang S (2017) Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study. World J Surg Oncol 15:196. https:\/\/doi.org\/10.1186\/s12957-017-1264-7","journal-title":"World J Surg Oncol"},{"key":"1109_CR17","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.amjsurg.2020.02.001","volume":"220","author":"J Goonawardena","year":"2020","unstructured":"Goonawardena J, Yong C, Law M (2020) Use of indocyanine green fluorescence compared to radioisotope for sentinel lymph node biopsy in early-stage breast cancer: systematic review and meta-analysis. Am J Surg 220:665\u2013676. https:\/\/doi.org\/10.1016\/j.amjsurg.2020.02.001","journal-title":"Am J Surg"},{"key":"1109_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4174\/astr.2019.97.1.1","volume":"97","author":"X Qin","year":"2019","unstructured":"Qin X, Yang M, Zheng X (2019) Comparative study of indocyanine green combined with blue dye with methylene blue only and carbon nanoparticles only for sentinel lymph node biopsy in breast cancer. Ann Surg Treat Res 97:1\u20136. https:\/\/doi.org\/10.4174\/astr.2019.97.1.1","journal-title":"Ann Surg Treat Res"},{"key":"1109_CR19","doi-asserted-by":"publisher","first-page":"e0135714","DOI":"10.1371\/journal.pone.0135714","volume":"10","author":"X Wu","year":"2015","unstructured":"Wu X, Lin Q, Chen G, Lu J, Zeng Y, Chen X, Yan J (2015) Sentinel lymph node detection using carbon nanoparticles in patients with early breast cancer. PLoS ONE 10:e0135714. https:\/\/doi.org\/10.1371\/journal.pone.0135714","journal-title":"PLoS ONE"},{"key":"1109_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12957-018-1414-6","volume":"16","author":"L Zhang","year":"2018","unstructured":"Zhang L, Huang Y, Yang C, Zhu T, Lin Y, Gao H, Yang M, Cheng M, Wang K (2018) Application of a carbon nanoparticle suspension for sentinel lymph node mapping in patients with early breast cancer: a retrospective cohort study. World J Surg Oncol 16:112. https:\/\/doi.org\/10.1186\/s12957-018-1414-6","journal-title":"World J Surg Oncol"},{"key":"1109_CR21","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/jog.13635","volume":"44","author":"SX Yang","year":"2018","unstructured":"Yang SX, Wei WS, Jiang QH, Zhou YF, Qu W, Tu JH, Ou-Yang QW, Zhou ZB, Ding HL, Xie CW (2018) Analysis of 246 sentinel lymph node biopsies of patients with clinical primary breast cancer by application of carbon nanoparticle suspension. J Obstet Gynaecol Res 44:1150\u20131157. https:\/\/doi.org\/10.1111\/jog.13635","journal-title":"J Obstet Gynaecol Res"},{"key":"1109_CR22","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Wolmark N (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11:927\u2013933. https:\/\/doi.org\/10.1016\/S1470-2045(10)70207-2","journal-title":"Lancet Oncol"},{"key":"1109_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1524-4741.2010.01019.x","volume":"17","author":"J Gill","year":"2011","unstructured":"Gill J, Lovegrove R, Naessens K, Pursell R, Cominos T, McCormick C, Umeh H, Courtney S, Smith B (2011) Sentinel lymph node biopsy in breast cancer: an analysis of the maximum number of nodes requiring excision. Breast J 17:3\u20138. https:\/\/doi.org\/10.1111\/j.1524-4741.2010.01019.x","journal-title":"Breast J"},{"key":"1109_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10147-016-1064-z","volume":"22","author":"T Sugie","year":"2017","unstructured":"Sugie T, Ikeda T, Kawaguchi A, Shimizu A, Toi M (2017) Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis. Int J Clin Oncol 22:11\u201317. https:\/\/doi.org\/10.1007\/s10147-016-1064-z","journal-title":"Int J Clin Oncol"},{"key":"1109_CR25","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1007\/s00268-020-05631-x","volume":"44","author":"RC Valiveru","year":"2020","unstructured":"Valiveru RC, Agarwal G, Agrawal V, Gambhir S, Mayilvaganan S, Chand G, Mishra A, Agarwal A, Mishra SK (2020) Low-cost fluorescein as an alternative to radio-colloid for sentinel lymph node biopsy-a prospective validation study in early breast cancer. World J Surg 44:3417\u20133422. https:\/\/doi.org\/10.1007\/s00268-020-05631-x","journal-title":"World J Surg"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-021-01109-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-021-01109-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-021-01109-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T18:06:45Z","timestamp":1637518005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-021-01109-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1109"],"URL":"https:\/\/doi.org\/10.1007\/s13304-021-01109-0","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]},"assertion":[{"value":"2 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no source of funding and no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethics committee of the Affiliated People\u2019s Hospital of Ningbo University (No. 009,107-P-066, February 18, 2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from each included patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (Institutional and National) and with the Helsinki Declaration of 1964 and later versions.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}